BioWorld Asia

Sep. 5, 2007

Acambis Wins FDA Approval For New Smallpox Vaccine

Acambis plc has won FDA approval for its smallpox vaccine ACAM 2000, the first new biodefense vaccine to be licensed since the U.S. government launched Project Bioshield in 2001. (BioWorld International) Read More

Jerini Goes Solo With Icatibant In U.S. As Abbott Walks Out

Speedel, Novartis Extending SPP100 Into Heart Failure

Forest Terminates Interest In Paion's Desmoteplase

Generic Epoetin Products Win Approval From EU

Other News To Note

Immutep Tests Lead Compound ImmuFact IMP321 In Melanoma

Heptares Spun Out of MRC To Become A Standalone

Trophos Raises €8.5M To Move Compound Into Phase II Trials

No Abstract Read More

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...